BioLineRx Gross Profit 2012-2018 | BLRX

BioLineRx gross profit from 2012 to 2018. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
BioLineRx Annual Gross Profit
(Millions of US $)
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
BioLineRx Quarterly Gross Profit
(Millions of US $)
Q4 2018 $0
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $0
Q3 2011 $0
Q2 2011 $0
Q1 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.040B $0.000B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.980B 31.89
Takeda Pharmaceutical (TAK) Japan $28.529B 10.56
Grifols (GRFS) Spain $12.699B 15.52
Ionis Pharmaceuticals (IONS) United States $10.053B 31.18
Sage Therapeutics (SAGE) United States $7.794B 0.00
Neurocrine Biosciences (NBIX) United States $7.309B 471.06
Jazz Pharmaceuticals (JAZZ) Ireland $7.187B 10.29
Catalent (CTLT) United States $6.414B 26.85
Nektar Therapeutics (NKTR) United States $5.397B 8.61
Tilray (TLRY) United States $5.016B 0.00
United Therapeutics (UTHR) United States $4.322B 7.35
Taro Pharmaceutical Industries (TARO) Israel $4.140B 13.33
FibroGen (FGEN) United States $4.007B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.832B 0.00
Portola Pharmaceuticals (PTLA) United States $2.302B 0.00
PTC Therapeutics (PTCT) United States $2.111B 0.00
USANA Health Sciences (USNA) United States $1.908B 16.01
Xencor (XNCR) United States $1.800B 0.00
Heron Therapeutics (HRTX) United States $1.798B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.769B 0.00
Aerie Pharmaceuticals (AERI) United States $1.759B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.746B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.625B 20.24
Madrigal Pharmaceuticals (MDGL) United States $1.615B 0.00
Endo (ENDP) Ireland $1.604B 2.47
Pacira Pharmaceuticals (PCRX) United States $1.598B 138.39
Zogenix (ZGNX) United States $1.578B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.336B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.288B 0.00
Esperion Therapeutics (ESPR) United States $1.123B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.052B 0.00
TherapeuticsMD (TXMD) United States $1.023B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.899B 0.00
CannTrust Holdings (CTST) Canada $0.776B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
ChemoCentryx (CCXI) United States $0.715B 0.00
ArQule (ARQL) United States $0.698B 0.00
Dermira (DERM) United States $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.586B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.582B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.576B 0.00
Forty Seven (FTSV) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.554B 0.00
GlycoMimetics (GLYC) United States $0.538B 0.00
TCR2 THERAPTCS (TCRR) United States $0.502B 0.00
Collegium Pharmaceutical (COLL) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.459B 23.68
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.423B 0.00
OptiNose (OPTN) United States $0.411B 0.00
Flexion Therapeutics (FLXN) United States $0.389B 0.00
Aptorum Group (APM) China $0.388B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 0.00
ImmunoGen (IMGN) United States $0.347B 0.00
Mast Therapeutics (SVRA) United States $0.346B 0.00
CASI Pharmaceuticals (CASI) United States $0.317B 0.00
Karyopharm Therapeutics (KPTI) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.284B 2.63
Minerva Neurosciences (NERV) United States $0.282B 0.00
Harpoon Therapy (HARP) United States $0.276B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.268B 9.93
AcelRx Pharmaceuticals (ACRX) United States $0.268B 0.00
Xeris Pharmaceuticals (XERS) United States $0.252B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.247B 0.00
Aclaris Therapeutics (ACRS) United States $0.243B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.238B 0.00
Dova Pharmaceuticals (DOVA) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.236B 0.00
Molecular Templates (MTEM) United States $0.226B 0.00
Concert Pharmaceuticals (CNCE) United States $0.223B 0.00
Rafael Holdings (RFL) United States $0.216B 0.00
MEI Pharma (MEIP) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.212B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.211B 0.00
Opexa Therapeutics (ACER) United States $0.207B 0.00
Affimed (AFMD) Germany $0.206B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.194B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.189B 0.00
Nature's Sunshine Products (NATR) United States $0.184B 191.20
Recro Pharma (REPH) United States $0.181B 0.00
Jounce Therapeutics (JNCE) United States $0.180B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
Majesco Entertainment (PTE) United States $0.175B 0.00
IMV INC (IMV) Canada $0.175B 0.00
ElectroCore (ECOR) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.170B 0.00
AgeX Therapeutics (AGE) United States $0.167B 0.00
Aratana Therapeutics (PETX) United States $0.165B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
Tyme Technologies (TYME) United States $0.157B 0.00
Aquestive Therapeutics (AQST) United States $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.147B 0.00
MediWound (MDWD) Israel $0.133B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.133B 0.00
China SXT Pharmaceuticals (SXTC) China $0.119B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
Neos Therapeutics (NEOS) United States $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.100B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.099B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Champions Oncology (CSBR) United States $0.095B 0.00
Zafgen (ZFGN) United States $0.094B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.092B 0.00
DURECT (DRRX) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.088B 0.00
Infinity Pharmaceuticals (INFI) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.077B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.063B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.058B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.044B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.040B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 4.69
IsoRay (ISR) United States $0.026B 0.00
Achieve Life Sciences (ACHV) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.36
PharmAthene (ALT) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NOVAN INC (NOVN) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.07
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Achaogen (AKAO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00